Cardinal Health Inc (NYSE:CAH) SVP Stuart G. Laws sold 804 shares of the stock in a transaction dated Tuesday, November 13th. The shares were sold at an average price of $55.55, for a total value of $44,662.20. Following the completion of the transaction, the senior vice president now directly owns 6,342 shares in the company, valued at $352,298.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of CAH stock traded up $0.80 during mid-day trading on Tuesday, reaching $56.73. The stock had a trading volume of 2,666,800 shares, compared to its average volume of 3,317,376. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.52 and a current ratio of 1.06. The firm has a market capitalization of $16.48 billion, a PE ratio of 11.35, a P/E/G ratio of 1.75 and a beta of 0.94. Cardinal Health Inc has a 1-year low of $48.14 and a 1-year high of $75.75.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, November 8th. The company reported $1.29 EPS for the quarter, topping the consensus estimate of $1.08 by $0.21. The firm had revenue of $35.21 billion for the quarter, compared to analyst estimates of $33.66 billion. Cardinal Health had a return on equity of 23.97% and a net margin of 0.53%. Cardinal Health’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the company earned $1.09 earnings per share. Sell-side analysts forecast that Cardinal Health Inc will post 5.02 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Investors of record on Wednesday, January 2nd will be issued a dividend of $0.4763 per share. This represents a $1.91 annualized dividend and a yield of 3.36%. The ex-dividend date of this dividend is Monday, December 31st. Cardinal Health’s dividend payout ratio (DPR) is 38.20%.

Cardinal Health announced that its board has approved a stock repurchase program on Thursday, November 8th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

A number of brokerages have recently weighed in on CAH. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating in a report on Tuesday. ValuEngine raised Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Monday. Royal Bank of Canada set a $57.00 price objective on Cardinal Health and gave the company a “hold” rating in a report on Friday. Argus cut their price objective on Cardinal Health from $85.00 to $75.00 and set a “buy” rating on the stock in a report on Monday, July 16th. Finally, Robert W. Baird cut their price objective on Cardinal Health from $51.00 to $50.00 and set a “neutral” rating on the stock in a report on Tuesday, August 7th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $61.08.

Institutional investors have recently bought and sold shares of the stock. LFA Lugano Financial Advisors SA acquired a new stake in Cardinal Health during the third quarter worth about $108,000. NEXT Financial Group Inc acquired a new stake in Cardinal Health during the third quarter worth about $111,000. First Hawaiian Bank acquired a new stake in Cardinal Health during the third quarter worth about $125,000. Sentry Investment Management LLC acquired a new stake in Cardinal Health during the second quarter worth about $132,000. Finally, Stelac Advisory Services LLC acquired a new stake in Cardinal Health during the third quarter worth about $164,000. 90.62% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This report was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2018/11/13/cardinal-health-inc-cah-svp-sells-44662-20-in-stock.html.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

See Also: What is the Dividend Aristocrat Index?

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.